Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

<h4>Background/aims</h4>Undetectable HCV RNA 12 weeks after the end of treatment (SVR12) has been the valid efficacy endpoint in the era of direct-acting antivirals (DAAs). Its concordance with SVR4 and SVR24 and long-term durability is unknown in Taiwanese chronic hepatitis C (CHC) patients.<h4>Met...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Chuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, Ming-Lun Yeh, Po-Yao Hsu, Cheng-Ting Hsu, Yu-Ju Wei, Ta-Wei Liu, Ming-Yen Hsieh, Nai-Jen Hou, Tyng-Yuang Jang, Yi-Hung Lin, Chih-Wen Wang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Public Library of Science (PLoS) 2021-01-01
Rangatū:	PLoS ONE
Urunga tuihono:	https://doi.org/10.1371/journal.pone.0245479
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Ngā tūemi rite